Total corporate nuclear verdict awards in 2024 — a 116% surge in a single year
Thermonuclear verdicts exceeding $100 million in 2024, nearly double the prior year
Current investment in the third-party litigation funding industry in the U.S.
A new financial weapon has entered the American courtroom — and it is reshaping the risk calculus for every organization that could ever face a lawsuit. Third-party litigation funding has transformed personal injury and wrongful death litigation from a high-stakes gamble into a high-return investment vehicle, with catastrophic consequences for defendants.
Imagine a case that ordinarily would settle for $250,000. A truck driver suffers a back injury. A slip and fall at a commercial property. A product liability claim that a plaintiff cannot afford to pursue past the initial filing. For decades, the economics of litigation kept such cases within predictable boundaries — both sides faced financial pressure to reach a reasonable settlement. That world no longer exists.
Today, hedge funds, private equity firms, and specialized litigation finance companies will write seven-figure checks to fund a plaintiff's case from complaint to verdict — in exchange for a share of any recovery. The financial pressure to settle is gone, replaced by a disciplined investor's calculus: push to trial, maximize the jury award, and collect the return. The result is a new category of risk that risk managers must understand as clearly as they understand flood zones or cyber threats.
From Niche Practice to $22 Billion Industry
Third-party litigation funding (TPLF) was almost unknown in the United States before 2010. Today it is a formidable industry. The last widely reported figure placed U.S. litigation funding investments at close to $22 billion, with projections suggesting the industry will exceed $67 billion annually by 2037. Approximately 20 percent of all commercial litigation funding in the United States is now directed to plaintiff cases — and much of this money is going directly to plaintiff attorneys pursuing bodily injury, wrongful death, and mass tort cases against corporations.
The mechanics are straightforward. A litigation funder reviews a plaintiff attorney's case portfolio the same way a venture capitalist reviews a startup pitch deck. If the case has strong liability facts, a sympathetic plaintiff, a well-funded defendant, and a plaintiff-friendly venue, the funder writes a check. If the case fails, the funder loses its investment — it is non-recourse. But if the case succeeds, the funder typically collects anywhere from 20 to 40 percent of the gross recovery, often before the plaintiff sees a dollar.
By removing financial pressure to settle, TPLF enables plaintiffs and their attorneys to reject reasonable offers and push cases to trial — transforming an ordinary claim into exposure that could exceed every insurance limit a company owns.
EPIC Insurance Brokers & Consultants, 2026
This arrangement changes the entire dynamic of civil litigation. Settlement, for centuries the pressure-release valve of the American legal system, loses its appeal when a funder is calculating its expected return on a trial verdict. A settlement offer that makes perfect sense for a plaintiff suddenly becomes a below-market offer when measured against what a jury in a "judicial hellhole" jurisdiction might award.
The Thermonuclear Verdict: A New Risk Benchmark
The consequences are written in the verdict data. In 2024, nuclear verdicts — jury awards exceeding $10 million — reached their highest level on record: 135 cases spread across 34 states and 77 courts. But the more telling number is what happened at the extreme end of the scale.
Thermonuclear verdicts — awards exceeding $100 million — nearly doubled in 2024, reaching 49 cases compared to 27 in 2023. Five verdicts surpassed the $1 billion threshold. The median nuclear verdict climbed to $51 million, up from $21 million just four years earlier — a 143 percent increase in the median alone. These are not outlier events. They represent a systematic shift in what American juries are willing to award.
The industries targeted read like a who's who of the U.S. economy: beverages ($8.5 billion in awards), entertainment ($4.7 billion), agricultural chemicals ($2.3 billion), construction and engineering ($2 billion), technology hardware ($1.9 billion), and oil and gas ($1.8 billion). No sector is immune.
A series of multi-billion dollar jury awards against a bottled water company whose products were alleged to contain hydrazine. Nevada had never previously ranked among the top states for nuclear verdict sums.
Continued Roundup/glyphosate litigation in which Philadelphia juries awarded multiple blockbuster verdicts in the same docket, with ongoing cases in the pipeline.
A former mechanic alleged cancer from benzene exposure. The court later upheld the verdict and added more than $90 million in delay damages.
A bellwether verdict in cow's milk-based infant formula litigation, with similar cases pending nationwide.
Antitrust verdict that reshaped the U.S. residential real estate industry, demonstrating that nuclear verdicts now extend far beyond traditional personal injury domains.
The median nuclear verdict has increased 143% since 2020. Companies on the losing end of nuclear verdicts historically see their stock prices decline an average of 22% in the years immediately following. This is no longer a tail risk — it is a core enterprise exposure.
The Plaintiff's Playbook: Three Weapons of Mass Verdict
Third-party funding is the financial engine, but it doesn't walk into the courtroom alone. Plaintiff attorneys have developed a sophisticated arsenal of psychological and tactical weapons that work in concert with TPLF to push verdicts into the stratosphere.
The Reptile Theory
Developed by jury consultant David Ball and plaintiff attorney Don Keenan, reptile theory bypasses logic and targets the most primitive part of the human brain — the survival instinct. Attorneys frame defendants as threats to community safety, not just the individual plaintiff. "If they did it to her, they'll do it to you." The authors claimed $7.7 billion in verdicts and settlements using this tactic. When it works, jurors stop asking "what are this plaintiff's damages?" and start asking "how do we stop this dangerous company?"
Anchoring
Plaintiff attorneys propose an extraordinarily high damages figure early in trial to create a psychological anchor in jurors' minds. Even when jurors consciously reject the anchor as excessive, their final award is disproportionately influenced by it. An attorney who asks for $500 million and "settles" the jury on $150 million has won an anchoring victory. TPLF supercharges this: a funder who needs a large return actively incentivizes attorneys to anchor high.
Phantom Damages
Medical billing features a massive gap between what providers charge and what insurers actually pay. Plaintiff attorneys present the full "sticker price" of medical bills rather than the amounts actually paid — inflating the compensatory baseline by millions of dollars before punitive damages are even discussed, giving the jury a distorted frame for "fair" compensation.
Forum Shopping + Attorney Advertising
With a funder's resources behind them, plaintiff attorneys can afford to file in the most favorable jurisdictions — Cook County IL, Philadelphia PA, Los Angeles, and St. Louis MO — even when the facts have little connection to those venues. Attorney advertising, now exceeding $2.4 billion annually in the U.S., shapes juror attitudes toward corporations before any trial begins, and recruits plaintiffs for mass tort campaigns packaged as investment portfolios for funders.
A well-funded plaintiff attorney uses TPLF resources to hire the best jury consultants, conduct extensive mock trials, retain top expert witnesses, and sustain years-long pre-trial discovery campaigns designed to unearth every internal document that can be used to paint a defendant as a reckless corporate actor. The resource asymmetry that once favored corporate defendants has been decisively flipped.
Social Inflation: The Hidden Tax on Every Business
The aggregate effect of TPLF, nuclear verdicts, and plaintiff tactics is "social inflation" — the increase in claims costs that exceeds normal economic inflation, driven by legal and social dynamics. For insurers, it is an existential pricing challenge. For risk managers, it is a direct cost of doing business.
As nuclear verdicts increase in frequency and magnitude, insurers are forced to reprice upward. Umbrella and excess liability limits that once seemed comfortably above any plausible verdict are now dangerously close to realistic jury award territory. The average cost of defending personal injury lawsuits increased 7.1 percent annually between 2016 and 2022. Defense firm billing rates rose another 6.5 percent through mid-2024. Organizations face a double burden: higher costs to defend, and higher payouts when cases go to trial.
Corporate mistrust, social pessimism, erosion of tort reform, and public desensitization to large numbers are among the most important factors driving the growth of nuclear verdicts. And a shift toward Millennial and Gen Z jurors — more pro-plaintiff, more anti-corporate — means the trend is structural, not cyclical.
Marathon Strategies, Corporate Verdicts Go Thermonuclear 2025 Edition
In an era of widespread institutional distrust, juries arrive in the courtroom already skeptical of large corporations, primed by years of attorney advertising. Reptile theory exploits this pre-existing sentiment with surgical precision, while TPLF ensures plaintiff attorneys have the resources to execute that exploitation at the highest possible level.
What This Means for Risk Managers: An ERM Framework
The emergence of TPLF-fueled nuclear and thermonuclear verdicts is not just a legal problem. It is an enterprise risk management problem that touches insurance adequacy, balance sheet resilience, reputational risk, and operational protocols. Every risk manager in an organization with public-facing operations, products, or services needs to address it systematically.
What Risk Managers Should Do Now
- Audit your liability limits immediately. If your umbrella or excess liability tower was sized against pre-2020 verdict benchmarks, it is almost certainly inadequate. The median nuclear verdict has more than doubled in four years. Model your exposure against current verdict data, not historical premiums.
- Identify your "judicial hellhole" exposures. If your operations, products, or customers are concentrated in Cook County, Philadelphia, Los Angeles, New York City, St. Louis, or Louisiana, your litigation risk profile is materially different from a comparable company operating only in states with tort reform. Map it explicitly.
- Train your organization on reptile theory awareness. Corporate representatives, safety personnel, and managers who may be deposed need to understand how their words and documentation will be weaponized. Document safety culture proactively and consistently.
- Build a TPLF early-warning process. Signs of a funded plaintiff: refusal of reasonable settlement offers, unusually sophisticated discovery campaigns, requests for corporate-level documents far exceeding the scope of the claim, and delays inconsistent with financial pressure on the plaintiff. Recognize these patterns early and escalate accordingly.
- Engage claims counsel before a nuclear verdict threat emerges. Defense strategy in TPLF-funded litigation must be calibrated from day one for a potential thermonuclear outcome. Waiting until the threat is obvious is waiting too long.
- Advocate for disclosure reform. Support legislative and regulatory efforts requiring disclosure of third-party litigation funders. Indiana, Montana, and other states have begun requiring it. Transparency is the single most effective systemic check on the TPLF-nuclear verdict feedback loop.
- Review safety and quality programs through a litigation lens. The best defense against a reptile theory attack is an organization that can credibly demonstrate it takes safety seriously at every level. Gap analyses of safety protocols, vendor due diligence, and quality control documentation should be reviewed regularly — not just for operational risk, but for litigation risk.
The Tort Reform Response — and Its Limits
Several states have taken meaningful steps to counter the nuclear verdict trend. Florida's 2023 comprehensive tort reform produced dramatic results: the state fell from the second-ranked venue for nuclear verdicts to tenth in just two years. Georgia enacted similar reforms in April 2025. Iowa capped trucking liability at $5 million. Indiana introduced TPLF disclosure requirements.
But tort reform is state-specific, politically volatile, and years behind the litigation trends it attempts to address. Florida's fall from second to tenth is encouraging — but it also reveals that nuclear verdict activity simply shifts to other venues. The aggregate national total continues to climb. Risk managers should welcome tort reform efforts while planning enterprise risk strategy on the assumption that the thermonuclear verdict environment is the new normal.
The Bottom Line
Third-party litigation funding has fundamentally changed the risk profile of civil litigation in the United States. Not by changing the law, but by changing the economics — and therefore the behavior — of the plaintiff's bar. Cases that would have settled are going to trial. Trials that would have produced manageable verdicts are producing generational financial catastrophes. And behind all of it, largely invisible to defendants, judges, and juries, are sophisticated financial investors optimizing for maximum return.
For risk managers, this demands an equally sophisticated response. Insurance adequacy, litigation strategy, safety culture, venue awareness, and regulatory advocacy all need to be calibrated to the thermonuclear reality. The organizations that recognize this shift and adapt will be in a far stronger position than those still managing litigation risk with a pre-2020 playbook.
The nuclear option is no longer a metaphor. It is a routine instrument of the plaintiff's bar. Risk managers who treat it accordingly will be the ones protecting their organizations when it is deployed.
